Understanding Monkeypox and other diseases in the Democratic Republic of the Congo
Official title: RFA-CK-22-001, Investigation of Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the Congo (DRC) - 2022
Funded at Kinshasa School of Public Health · NIH-11190764 · Data updated 2026-11-12
This study is working to better understand Monkeypox and similar diseases in the Democratic Republic of the Congo by training health workers, improving how we collect data, and testing new ways to diagnose and treat these illnesses, all to help keep communities safer during outbreaks.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kinshasa School of Public Health NIH-funded |
| Lab location | 1 site (Kinshasa, Congo Dem Rep) |
| Project start | September 30, 2022 |
| Project end | September 29, 2027 |
| Funding year | 2024 |
| Award (this year) | $100,000 |
| NIH project number | 6U01CK000666-03M001 |
| Project ID | NIH-11190764 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals living in high-risk areas of the DRC, particularly those affected by Monkeypox or other zoonotic diseases.
✕Less likely to help
Patients outside of the Democratic Republic of the Congo or those not at risk for zoonotic diseases may not receive any benefit from this research.
What this research studies
This research aims to enhance the understanding of Monkeypox and other zoonotic diseases in the Democratic Republic of the Congo (DRC) by establishing a laboratory-based surveillance system. It will involve training public health practitioners, improving geographic data collection, and assessing new diagnostic methods. The project will also conduct clinical trials for treatments and vaccines, and perform serosurveys to identify transmission risks. By collaborating with local health systems, the research seeks to strengthen outbreak response capabilities.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for Monkeypox and other zoonotic diseases, ultimately reducing their impact on public health.
How similar studies have gone: Previous research has shown success in improving public health responses to zoonotic diseases through similar surveillance and training approaches.
Where this research is happening
-
Kinshasa School of Public Health
Kinshasa, Congo Dem Rep Active
Researchers
- Principal investigator: Kaba, Didine Kinkodi — Kinshasa School of Public Health
- Study coordinator: Kaba, Didine Kinkodi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.